Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Johnson & Johnson
(NY:
JNJ
)
147.13
+0.05 (+0.03%)
Official Closing Price
Updated: 7:00 PM EDT, Jun 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Johnson & Johnson
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
95
96
Next >
The Best Stocks to Invest $5,000 In Right Now
October 24, 2023
Today, the following three healthcare players look like fantastic bargains.
Via
The Motley Fool
2 Historically Cheap Dow Dividend Kings That Are Ripe for the Picking
October 24, 2023
These inexpensive Dow components have achieved royalty status among income stocks -- more than 60 consecutive years of dividend increases.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
10 Health Care Stocks With Whale Alerts In Today's Session
October 23, 2023
Via
Benzinga
Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted
October 22, 2023
Jada Pinkett Smith Opens Up About Ayahuasca: It Helped Her Overcome Depression And Suicidal Thoughts
Via
Benzinga
Check Out What Whales Are Doing With JNJ
October 19, 2023
Via
Benzinga
Down in the Double Digits, These 2 Classic Warren Buffett Stocks Make Great Buys Now
October 22, 2023
These players could deliver top returns over the long haul.
Via
The Motley Fool
3 Foundational Blue Chip Dow Dividend Stocks for Building Generational Wealth
October 22, 2023
Dow stocks can provide the confidence needed to hold through periods of volatility.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
2 Warren Buffett Dividend Stocks to Buy and Hold Forever
October 21, 2023
Most people have come across these companies' services.
Via
The Motley Fool
These 2 Dow Stocks Moved Markets This Week
October 21, 2023
Bulls and bears alike looked closely at these two companies.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Intuitive Surgical's Revenue Dipped: Is It Time to Sell?
October 21, 2023
A stagnating top line isn't what investors want to see, but things might not be as bad as the surgical robot specialist's stock price performance would suggest.
Via
The Motley Fool
Stock Market Struggles As Treasury Yields Soar; Tesla, Nvidia Among Notable Losers: Weekly Review
October 20, 2023
The major indexes saw significant loses as Treasury yields soared.
Via
Investor's Business Daily
3 Mutual Funds to Invest in for Pro Management and Low Fees
October 20, 2023
People wanting to invest for the future without actively managing their own money should consider one of these top mutual funds.
Via
InvestorPlace
The 7 Best Forever Stocks To Buy Now: October 2023
October 19, 2023
These best forever stocks have consistently grown their cash flows even in uncertain times and are category leaders set for dominance.
Via
InvestorPlace
7 Healthcare Stocks That Can Cure a Lackluster Portfolio
October 19, 2023
Take a position in these companies' stocks to achieve long-term gains and give a jolt to your investment portfolio.
Via
InvestorPlace
Is Johnson & Johnson Still a Good Dividend Stock to Buy?
October 19, 2023
Investors wonder if the healthcare giant can keep raising its payout now that it no longer sells the consumer health brands that made it famous.
Via
The Motley Fool
7 Dividend Aristocrats That Are Built to Last
October 19, 2023
For dependability and durability, take a closer look at these seven dividend stocks, all of which hold aristocratic status.
Via
InvestorPlace
Why Johnson & Johnson Stock Flopped Today
October 18, 2023
Perhaps those third-quarter results weren't as impressive as they first appeared to be.
Via
The Motley Fool
Positive Outlook On Johnson & Johnson's Partner Legend Biotech: Analyst Confident On Blood Cancer Drug
October 18, 2023
Legend Biotech Corporation's (NASDAQ: LEGN) partner, Johnson & Johnson (NYSE: JNJ), reported Q3 Carvykti revenues of $152 million,
Via
Benzinga
1 Warren Buffett Stock to Buy Hand Over Fist Right Now
October 18, 2023
This blue-chip healthcare stock is a solid pick for investors in uncertain times.
Via
The Motley Fool
Dividend Income Update September 2023
October 18, 2023
With the start of the final quarter of 2023, it’s time to take a look back at my previous month of dividend income.
Via
Talk Markets
Is the "New" Johnson & Johnson Stock a Buy With Its Improved Profit Outlook?
October 18, 2023
Some things are different about J&J. But other things remain the same as they've been for a long time.
Via
The Motley Fool
Johnson & Johnson's Sharper Focus Is Already Paying Dividends for Investors
October 17, 2023
The healthcare behemoth reported strong earnings after separating its consumer health division.
Via
The Motley Fool
Back for Another Round: Rate Hike Fears Grow After Strong Retail Sales Sends Yields Spinning Higher
October 17, 2023
(Tuesday market open) Early earnings results continued to impress but major indexes flagged in premarket trading Tuesday as Treasury yields swung higher after unexpectedly strong September U.S. Retail...
Via
Benzinga
Johnson & Johnson's Q3 2023: $21.3B Rise In Sales, 'Sharpened Focus' On Innovation & Biotech Solutions
October 17, 2023
Healthcare company Johnson & Johnson (J&J) (NYSE: JNJ) shared its financial outcomes for the third quarter of 2023, reflecting:
Via
Benzinga
Johnson & Johnson (JNJ) Q3 2023 Earnings Call Transcript
October 17, 2023
JNJ earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Johnson & Johnson Was Saved By Its Focus On MedTech And Innovative Medicine
October 17, 2023
Johnson & Johnson (NYSE: JNJ) reported its third quarter results that topped Wall Street’s expectations while also lifting its full year guidance fueled by a strong performance of its pharmaceutical...
Via
Benzinga
Iran Warning Stops The Market Rally Buy Historic Biden Visit To Israel Is A Positive For The Market
October 17, 2023
To gain an edge, this is what you need to know today.
Via
Benzinga
Johnson & Johnson Is Falling, but This Tech Stock Is Really Getting Hit Hard
October 17, 2023
Earnings season is starting to ramp up.
Via
The Motley Fool
Johnson & Johnson Raises Outlook As The Health Care Bellwether Beats Views
October 17, 2023
The company beat third-quarter forecasts and raised its outlook for the year. It's now focusing on innovative drugs and medtech following its consumer health spinoff.
Via
Investor's Business Daily
New Johnson & Johnson's Q3 Earnings Beat Street View, Raises Annual Outlook
October 17, 2023
Johnson & Johnson (NYSE: JNJ) has reported Q3 FY23 adjusted earnings of $2.66 per share, up 19.3% Y/Y and beating the conse
Via
Benzinga
Topics
Earnings
Exposures
Financial
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
95
96
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.